Gary Patou

Director

Gary Patou (Director) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in Xenon Pharmaceuticals Inc. (XENE). The largest single filing was $117K of XENE (2,851 sh × $41.11, as filed), executed Nov 22 2024.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 1 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$117K

shares × price, as filed

Last traded

Nov 22 2024

Filed Nov 22 2024

Median ADV $85.7M across their filed names

Open performance→

Volume by month

Buys $0 Sells $117K

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 1 filing

Sector per market data · by filing · past 24 months

Most traded names

XENE

Xenon Pharmaceuticals Inc. XENE · 0 buys · 1 sell 1 filing

Recent filings

XENESALE Xenon Pharmaceuticals Inc. View filing → $117K
2,851 sh × $41.11
Exec Nov 22 2024
Filed Nov 22 2024 · 5:30 PM ET